Drug Store News - Schering-Plough - losses appeal over Claritin generics - Brief Article
Schering-Plough earlier this month lost its appeal of a U.S. court decision that found generic equivalents to the company’s Claritin (loratadine) drug were not in violation of patents protecting Clarinex (desloratadine).
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
3 Questions No Job Seeker Ever Wants To Be Asked?
5 Regular Mistakes In Public Speaking
A New Jersey court in August 2002 ruled against Schering-Plough’s patent claims and the U.S. Court of Appeals for the Federal Circuit affirmed that decision Aug. 1.
COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
